In the study of cervical cancer, it was found that empagliflozin could activate AMPK phosphorylation, down-regulate the expression of FOXA1, and thus inhibit the expression of SHH, inhibit the malignant proliferation of cervical cancer cells and induce apoptosis (60). Here, FOXA1 is linked to cervical cancer.